Resonance Specialties Limited (BOM:524218)

Market Cap	1.46B +60.4%
Revenue (ttm)	918.89M +18.1%
Net Income	103.96M +58.3%
EPS	9.01 +58.4%
Shares Out	11.54M
PE Ratio	14.02
Forward PE	n/a
Dividend	1.00 (0.79%)
Ex-Dividend Date	Jul 28, 2026

Volume	13,524
Open	122.52
Previous Close	122.88
Day's Range	120.05 - 128.77
52-Week Range	77.00 - 142.90
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	May 14, 2026

About Resonance Specialties

Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in manufacturing agrochemicals, pharmaceuticals and bulk drugs, dyes, rubber chemicals, etc.; cyanopyridines that are applied in manufacturing of niacinamide; and picolines, including alpha, beta, and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and anti-tuberculosis drugs. The company also provides nutritional drug products, such as zinc and chromium picolinate,...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 66
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524218

Financial Performance

In fiscal year 2026, Resonance Specialties's revenue was 918.89 million, an increase of 18.10% compared to the previous year's 778.07 million. Earnings were 103.96 million, an increase of 58.32%.